Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of immunotherapy in non-clear cell renal cell carcinoma.
Climent C, Soriano S, Bonfill T, Lopez N, Rodriguez M, Sierra M, Andreu P, Fragio M, Busquets M, Carrasco A, Cano O, Seguí MA, Gallardo E. Climent C, et al. Among authors: gallardo e. Front Oncol. 2023 Feb 3;13:941835. doi: 10.3389/fonc.2023.941835. eCollection 2023. Front Oncol. 2023. PMID: 36816976 Free PMC article. Review.
Phase I study of sunitinib in combination with gemcitabine and capecitabine for first-line treatment of metastatic or unresectable renal cell carcinoma.
Bellmunt J, Suarez C, Gallardo E, Rodon J, Pons F, Bonfill T, Beltran M, Moya I, Galtes S, Albanell J, Carles J. Bellmunt J, et al. Among authors: gallardo e. Oncologist. 2014 Sep;19(9):917-8. doi: 10.1634/theoncologist.2014-0072. Epub 2014 Aug 20. Oncologist. 2014. PMID: 25142843 Free PMC article. Clinical Trial.
Prognostic and Predictive Factors for Renal Cell Carcinoma.
Suárez C, Campayo M, Bastús R, Castillo S, Etxanitz O, Guix M, Sala N, Gallardo E. Suárez C, et al. Among authors: gallardo e. Target Oncol. 2018 Jun;13(3):309-331. doi: 10.1007/s11523-018-0557-2. Target Oncol. 2018. PMID: 29569164 Review.
Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients.
Carles J, Gallardo E, Doménech M, Font A, Bellmunt J, Figols M, Mellado B, Sáez MI, Suárez C, Méndez MJ, Maroto P, Luque R, de Portugal T, Aldabo R, Bonfill T, Morales-Barrera R, García J, Maciá S, Maldonado X, Foro P. Carles J, et al. Among authors: gallardo e. Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):344-352. doi: 10.1016/j.ijrobp.2018.10.005. Epub 2018 Oct 12. Int J Radiat Oncol Biol Phys. 2019. PMID: 30321689 Clinical Trial.
Effect of muscle density in patients with metastatic prostate cancer administered androgen deprivation therapy.
Muñoz-Rodríguez J, Domínguez A, Rosado MA, Centeno C, Parejo V, Costa-Trachsel I, Gallardo E, Bonfill T, García-Rojo D, De Verdonces L, Prats J. Muñoz-Rodríguez J, et al. Among authors: gallardo e. Endocrinol Diabetes Nutr (Engl Ed). 2021 Feb;68(2):92-98. doi: 10.1016/j.endinu.2020.03.014. Epub 2020 Aug 20. Endocrinol Diabetes Nutr (Engl Ed). 2021. PMID: 32828709 English, Spanish.
523 results